X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855899/0/en/Pliant-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
https://www.globenewswire.com/news-release/2024/03/27/2853326/0/en/Pliant-Therapeutics-Announces-Upcoming-Presentations-at-the-2024-American-Thoracic-Society-International-Conference.html
https://www.globenewswire.com//news-release/2024/03/12/2844430/0/en/Pliant-Therapeutics-Announces-Accelerated-Bexotegrast-Development-Plan-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html
https://www.globenewswire.com//news-release/2024/02/27/2836427/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/26/2835091/0/en/Pliant-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/07/2825150/0/en/Pliant-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
https://www.globenewswire.com/news-release/2024/02/04/2823179/0/en/Pliant-Therapeutics-Announces-Positive-Safety-and-Exploratory-Efficacy-Data-from-the-INTEGRIS-PSC-Phase-2a-Trial-of-Bexotegrast-320-mg-in-Patients-with-Primary-Sclerosing-Cholangit.html
https://www.globenewswire.com//news-release/2024/01/03/2803235/0/en/Pliant-Therapeutics-to-Participate-in-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2779524/0/en/Pliant-Therapeutics-Presentations-at-The-Liver-Meeting-2023-Highlight-Bexotegrast-an-Inhibitor-of-%CE%B1v%C3%9F6-and-%CE%B1v%C3%9F1-Integrins-in-Primary-Sclerosing-Cholangitis.html
https://www.globenewswire.com//news-release/2023/11/09/2777821/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2023-Financial-Results.html
Market Place
Share 
